Prosecution Insights
Prosecution Insights
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (25%) |
| §101 + other | 2 (50%) |
| §103 only | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HAIDER, SYED | 1 | 83.5% | +8.0% |
| DAUNER, JOSEPH G | 1 | 56.8% | +35.6% |
| WHALEY, PABLO S | 1 | 25.3% | +21.5% |
| GOLDBERG, JEANINE ANNE | 1 | 45.9% | +40.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18742623 | METHOD OF CELL-CLUSTER ANALYSIS | HAIDER, SYED | — |
| 18669240 | METHOD AND BIOMARKERS FOR ASSESSING THE RISK AND PROGNOSTIC LEVEL OF METASTATIC COLORECTAL CANCER | DAUNER, JOSEPH G | — |
| 17728224 | METHOD AND KIT FOR EVALUATING PROGNOSIS IN PATIENT WITH BREAST CANCER | WHALEY, PABLO S | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17604847 | METHODS FOR ASSESSING THE RISK OF DEVELOPING SEVERE CUTANEOUS ADVERSE DRUG REACTIONS INDUCED BY DISEASE-MODIFYING ANTIRHEUMATIC DRUGS, DETECTION KIT THEREOF AND USES THEREOF | GOLDBERG, JEANINE ANNE | 1d overdue |
| 18669240 | METHOD AND BIOMARKERS FOR ASSESSING THE RISK AND PROGNOSTIC LEVEL OF METASTATIC COLORECTAL CANCER | DAUNER, JOSEPH G | — |
| 17728224 | METHOD AND KIT FOR EVALUATING PROGNOSIS IN PATIENT WITH BREAST CANCER | WHALEY, PABLO S | — |
| Art Unit | Apps |
|---|---|
| 2633 | 1 |
| 3619 | 1 |
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18742623 | METHOD OF CELL-CLUSTER ANALYSIS | HAIDER, SYED | 2633 | §101 | Non-Final OA | — | Pending | Jun 13, 2024 |
| 18669240 | METHOD AND BIOMARKERS FOR ASSESSING THE RISK AND PROGNOSTIC LEVEL OF METASTATIC COLORECTAL CANCER | DAUNER, JOSEPH G | — | §101§102§103§112 | Non-Final OA | — | Pending | May 20, 2024 |
| 17728224 | METHOD AND KIT FOR EVALUATING PROGNOSIS IN PATIENT WITH BREAST CANCER | WHALEY, PABLO S | 3619 | §101§102§112 | Non-Final OA | — | Pending | Apr 25, 2022 |
| 17604847 | METHODS FOR ASSESSING THE RISK OF DEVELOPING SEVERE CUTANEOUS ADVERSE DRUG REACTIONS INDUCED BY DISEASE-MODIFYING ANTIRHEUMATIC DRUGS, DETECTION KIT THEREOF AND USES THEREOF | GOLDBERG, JEANINE ANNE | 1682 | §103 | Non-Final OA | 1d overdue | Pending | Oct 19, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial